CSPC Pharmaceutical Group Limited: Diabetes Mellitus trials

The registry lists 11 Diabetes Mellitus studies with CSPC Pharmaceutical Group Limited as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 3Phase 3 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of SYH2069 Injection in Healthy ParticipantsActive, not recruitingNCT07736391Phase 1
• A Study of TG103 Injection in Type 2 Diabetes SubjectsStatus unknownNCT05348122Phase 2
• A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedNCT05146869Phase 1
• A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 DiabetesStatus unknownNCT05063253Phase 2
• A Study of TG103 Injection in Overweight/Obese Subjects Without DiabetesCompletedNCT04855292Phase 1
• A Study of TG103 in Subjects With Type 2 DiabetesStatus unknownNCT04790006Phase 1
• A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DMCompletedNCT04218734Phase 3
• A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus PatientsCompletedNCT04161430Phase 3
• DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedNCT04124484Phase 2
• Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 DiabetesCompletedNCT03940183Phase 3
• The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes MellitusStatus unknownNCT03239119Phase 3